Dr Edward Shelton
Dr Edward Shelton
Monash Health
Verified email at yarragastro.com.au
Title
Cited by
Cited by
Year
Efficacy of vedolizumab as induction therapy in refractory IBD patients: a multicenter cohort
E Shelton, JR Allegretti, B Stevens, M Lucci, H Khalili, DD Nguyen, J Sauk, ...
Inflammatory bowel diseases 21 (12), 2879-2885, 2015
1692015
Cancer recurrence following immune-suppressive therapies in patients with immune-mediated diseases: a systematic review and meta-analysis
E Shelton, D Laharie, FI Scott, R Mamtani, JD Lewis, JF Colombel, ...
Gastroenterology 151 (1), 97-109. e4, 2016
1032016
New onset idiosyncratic liver enzyme elevations with biological therapy in inflammatory bowel disease
E Shelton, K Chaudrey, J Sauk, H Khalili, R Masia, DD Nguyen, V Yajnik, ...
Alimentary pharmacology & therapeutics 41 (10), 972-979, 2015
502015
Late onset Pneumocystis pneumonia in patients receiving rituximab for humoral renal transplant rejection
E Shelton, M Yong, S Cohney
Nephrology 14 (7), 696-699, 2009
502009
Risk stratification of upper GI bleeding with an esophageal capsule
S Chandran, A Testro, P Urquhart, R La Nauze, S Ong, E Shelton, ...
Gastrointestinal endoscopy 77 (6), 891-898, 2013
312013
Safety and Efficacy of Teduglutide (Gattex) in patients with Crohn’s disease and need for parenteral support due to short bowel syndrome associated intestinal failure
B Kochar, MD Long, E Shelton, L Young, FA Farraye, V Yajnik, H Herfarth
Journal of clinical gastroenterology 51 (6), 508, 2017
272017
Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn's Disease and Need for Parenteral Support Due to Short Bowel Syndrome-associated Intestinal Failure.
HH Bharati Kochar, Millie D Long, Edward Shelton, Lorraine Young, Francis A ...
Journal of Clinical Gastroenterology, 2016
27*2016
A randomized controlled study of trimethoprim‐sulfamethoxazole versus norfloxacin for the prevention of infection in cirrhotic patients
S Lontos, E Shelton, PW Angus, R Vaughan, SK Roberts, A Gordon, ...
Journal of digestive diseases 15 (5), 260-267, 2014
262014
Electronic estimations of renal function are inaccurate in solid-organ transplant recipients and can result in significant underdosing of prophylactic valganciclovir
J Trevillyan, P Angus, E Shelton, J Whitlam, F Ierino, J Pavlovic, ...
Antimicrobial agents and chemotherapy 57 (8), 4058-4060, 2013
122013
Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure
E Flanagan, PR Gibson, EK Wright, GT Moore, MP Sparrow, W Connell, ...
Alimentary Pharmacology & Therapeutics 52 (10), 1551-1562, 2020
62020
Gastrointestinal: balloon pancreatitis
E Shelton, P Froomes, MA Fink
Journal of gastroenterology and hepatology 27 (5), 986-986, 2012
62012
Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population
G Maconi, C Bosetti, A De Monti, RK Boyapati, E Shelton, N Piazza, ...
Digestive and Liver Disease 53 (3), 263-270, 2021
52021
Tu1359 Efficacy of Vedolizumab As Induction Therapy in Refractory IBD Patients Following Multiple Anti-TNF Therapy Failures
BW Stevens, E Shelton, J Sauk, H Khalili, DD Nguyen, M White-Guthro, ...
Gastroenterology 148 (4), S-869, 2015
52015
Immunomodulator use does not prevent first loss of response to anti-TNF therapy in inflammatory bowel disease: long term outcomes in a real-world cohort
P Varma, AS Rajadurai, DQ Holt, DA Devonshire, CP Desmond, ...
Intern Med J 49, 685-810, 2018
32018
Hepatic Fibrosis Is Common in ‚-Thalassaemia and Is Associated with Current and Historical Iron Loading and Hepatitis C
E Shelton, CP Chong, L Shochet, SY Ong, DK Bowden, V Knight, ...
Journal of Hepatitis 2 (1), 2016
22016
Comparison of Adalimumab Serum Drug Levels When Delivered by Pen Versus Syringe in Patients With Inflammatory Bowel Disease. An International, Multicentre Cohort Analysis
RD Little, IE Chu, EP van der Zanden, E Flanagan, SJ Bell, PR Gibson, ...
Journal of Crohn's and Colitis 13 (12), 1527-1536, 2019
12019
Immunomodulator use does not prevent first loss of response to anti-tumour necrosis factor alpha therapy in inflammatory bowel disease: long-term outcomes in a real-world cohort.
P Varma, AS Rajadurai, DQ Holt, DA Devonshire, CP Desmond, ...
Internal medicine journal 49 (6), 753-760, 2019
12019
Efficacy of vedolizumab as induction therapy in refractory IBD patients: a multicentre cohort
E Shelton, J Allegretti, B Stevens, M Lucci, A Ananthakrishnan, V Yajnik
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 30, 138-139, 2015
12015
LATE ONSET PNEUMOCYSTIS PNEUMONIA IN PATIENTS RECEIVING RITUXIMAB FOR ANTIBODY MEDIATED RENAL TRANSPLANT REJECTION: 1173.
S Cohney, M Yong, E Shelton
Transplantation 86 (2S), 398-399, 2008
12008
Possible association of autoimmune hepatitis and splenic artery aneurysms.
E Shelton, R Dowling, G Taggart, AJ Nicoll
Liver international: official journal of the International Association for†…, 2008
12008
The system can't perform the operation now. Try again later.
Articles 1–20